Discovery, design and synthesis of novel potent and selective sphingosine-1-phosphate 4 receptor (S1P4-R) agonists

Potent and exquisitely selective agonists of the sphingosine-1-phosphate 4 receptor (S1P4-R) have been reported. The molecules herein disclosed provide novel pharmacological tools to decipher the biological function and assess the therapeutic utility of the target receptor. High affinity and selecti...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters 2012-01, Vol.22 (1), p.537-542
Main Authors: Guerrero, Miguel, Urbano, Mariangela, Zhao, Jian, Crisp, Melissa, Chase, Peter, Hodder, Peter, Schaeffer, Marie-Therese, Brown, Steven, Rosen, Hugh, Roberts, Edward
Format: Article
Language:English
Subjects:
agonists
Animals
Autoimmune diseases
Biological and medical sciences
Chemistry, Pharmaceutical - methods
Dendritic Cells - cytology
Drug Design
Humans
Immunosuppressive Agents - pharmacology
Lymphocytes - cytology
Medical sciences
Mice
Models, Chemical
Pharmacology. Drug treatments
Receptors, Lysosphingolipid - agonists
S1P4 receptor
screening
Selective small molecule S1P4-R agonists
Structure-Activity Relationship
structure-activity relationships
Thrombocytopenia
Viral infections
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Potent and exquisitely selective agonists of the sphingosine-1-phosphate 4 receptor (S1P4-R) have been reported. The molecules herein disclosed provide novel pharmacological tools to decipher the biological function and assess the therapeutic utility of the target receptor. High affinity and selective small molecule agonists of the S1P4 receptor (S1P4-R) may have significant therapeutic utility in diverse disease areas including autoimmune diseases, viral infections and thrombocytopenia. A high-throughput screening (HTS) of the Molecular Libraries-Small Molecule Repository library identified 3-(2-(2,4-dichlorophenoxy)ethoxy)-6-methyl-2-nitropyridine as a moderately potent and selective S1P4-R hit agonist. Design, synthesis and systematic structure–activity relationships study of the HTS-derived hit led to the development of novel potent S1P4-R agonists exquisitely selective over the remaining S1P1–3,5-Rs family members. Remarkably, the molecules herein reported provide novel pharmacological tools to decipher the biological function and assess the therapeutic utility of the S1P4-R.
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2011.10.096